Amelia Merrill - Aug 11, 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
SVP, People
Signature
/s/ John Saia, as attorney-in-fact for Amelia Merrill
Stock symbol
GH
Transactions as of
Aug 11, 2022
Transactions value $
-$484,666
Form type
4
Date filed
8/15/2022, 05:59 PM
Previous filing
Sep 13, 2022
Next filing
Nov 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $20.9K +5K +20.65% $4.18* 29.2K Aug 11, 2022 Direct
transaction GH COMMON STOCK Sale -$240K -4.5K -15.41% $53.38 24.7K Aug 11, 2022 Direct F1
transaction GH COMMON STOCK Sale -$244K -4.5K -18.21% $54.32 20.2K Aug 12, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Options Exercise -$20.9K -5K -12.91% $4.18* 33.7K Aug 11, 2022 COMMON STOCK 5K $4.18 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $53.32 to $53.53, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $54.16 to $54.465, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F3 The stock option vests and becomes exercisable as to 25% of the shares on May 1, 2018, and then in equal monthly installments through May 1, 2021.